Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota
EDAP's Ablatherm® Robotic HIFU Treatments Performed at University of Minnesota LYON, France , February 27, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at the University of Minnesota , Minneapolis ,
View HTML
Toggle Summary EDAP Announces Preliminary Unaudited Full Year 2016 Revenue
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue Full year 2016 revenue increased to approximately €35.6 million  2016 HIFU revenues recorded over 63% growth Strong cash position of €22 million Company to announce fourth quarter and full year 2016 results April 3rd with accompanying
View HTML
Toggle Summary EDAP to Exclusively Distribute LABORIE's Medical Measurement Systems Urodynamic Products in Japan
LYON, France , Jan. 23, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (NASDAQ:EDAP), the global leader in therapeutic ultrasound, announced today that it has signed an exclusive agreement with the Canadian company LABORIE to distribute their urodynamic diagnostic products in Japan , one of the largest
View HTML
Toggle Summary EDAP to Host Meetings with Investors During JP Morgan Healthcare Conference Week
LYON, France , Jan. 04, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it will be hosting meetings with analysts and investors during the JP Morgan Healthcare conference week, January 9th & 10th in San Francisco, CA.
View HTML
Toggle Summary EDAP Reports Superior Outcomes of Focal Ablatherm-HIFU Compared to Robotic Radical Prostatectomy
Similar Cancer Control at 5 Years, Significantly Less Incidence of Incontinence and Erectile Dysfunction
View HTML
Toggle Summary EDAP Announces Focal One® HIFU Sale to Foch Hospital, Paris
Growing Adoption of Focal One HIFU in France
View HTML
Toggle Summary EDAP TMS Retains CG Capital as New Investor Relations Counsel
LYON, France , Dec. 12, 2016 (GLOBE NEWSWIRE) -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in therapeutic ultrasound today announced that it has retained CG Capital , a leading capital markets development and research firm as their new investor relations counsel.
View HTML
Toggle Summary EDAP Receives the Prestigious Prix Galien for its Focal One® HIFU device
LYON, France , Dec. 08, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the award of the prestigious 2016 Prix Galien, in the Medical Device category, for its Focal One HIFU device dedicated to the treatment of localized prostate
View HTML
Toggle Summary EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016
Highlights at the end of September 30, 2016 : Total cumulated revenue in 2016  up 22% year-over-year; Driven by HIFU growth, Gross Margin increases to 45%; 111% growth in HIFU revenues in Q3 of 2016 compared to Q3 2015; Company continues to show operating profit in 2016 at the end of Q3; Strong
View HTML
Toggle Summary EDAP to Report Third Quarter 2016 Financial Results on November 17, 2016
Conference Call and Webcast Scheduled for 8:30 a.m. ET
View HTML